Table 1.

Summary of clinical trials using YM155 in cancer.

Study Identifier	Number of Patients	Phase	Disease	Date Ended
NCT01023386	6	phase 1	cancer	2010
NCT00818480	10	phase 2	prostate cancer, melanoma, non-Hodgkin′s Lymphoma	2012
NCT01007292	43	phase 2	non-Hodgkin′s Lymphoma	2015
NCT01009775	64	phase 2	melanoma	2012
NCT01038804	101	phase 2	breast cancer	2013
NCT00498914	41	phase 2	lymphoma	2009
NCT01100931	42	phase 1/2	NSCLC 2, solid tumors	2015
NCT00514267	32	phase 1/2	prostate cancer, tumors	2015
NCT00281541	29	phase 2	melanoma	2012
NCT00328588	37	phase 2	NSCLC 2	2008
NCT00257478	NA 1	phase 2	prostate cancer	2007

¹ No data available. ² Non-small Cell Lung Cancer.